Inventor · disambiguated record
Yatin R. Gokarn
Also filed as: GOKARN YATIN · GOKARN YATIN R
5 granted patents·24 pending applications·20 citations·filing 2003–2022
78Inventor score
Top patents by PatentIndex Score
29 records- 0182US9932591B2Reduction of lipase activity in product formulationsLEE KELVIN·Filed 2014·Granted Apr 3, 2018·6 cites·4 claims
- 0280US9226961B2Antibody formulationGENENTECH INC·Filed 2013·Granted Jan 5, 2016·7 cites·63 claims
- 0379US11607451B2Self-buffering antibody formulationsAMGEN INC·Filed 2013·Granted Mar 21, 2023·1 cites·96 claims
- 0477US10570397B2Reduction of lipase activity in product formulationsUNIV OF DELEWARE·Filed 2018·Granted Feb 25, 2020·3 cites·2 claims
- 0571US10010611B2Antibody formulationsGENENTECH INC·Filed 2014·Granted Jul 3, 2018·3 cites·15 claims
- 0663US2017368170A1Self-buffering protein formulationsAMGEN INC·Filed 2017·Application pending·0 cites
- 0762US2020179516A1Antibody formulationsGENENTECH INC·Filed 2019·Application pending·0 cites
- 0861US2020392220A1Antibody formulationGENENTECH INC·Filed 2020·Application pending·0 cites
- 0960US2016367666A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1059US2016367665A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1159US2016319011A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1259US2016362486A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1359US2019390203A1Reduction of lipase activity in product formulationsLEE KELVIN·Filed 2019·Application pending·0 cites
- 1459US2016339102A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1559US2016362484A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1659US2016362485A1Self-buffering protein formulationsAMGEN INC·Filed 2016·Application pending·0 cites
- 1756US2008311078A1Self-Buffering Protein FormulationsGOKARN YATIN R·Filed 2006·Application pending·0 cites
- 1855US2012028877A1Self-Buffering Protein FormulationsGOKARN YATIN R·Filed 2011·Application pending·0 cites
- 1952US2018171004A1Antibody formulationGENENTECH INC·Filed 2017·Application pending·0 cites
- 2050US2019345238A1FormulationsAMGEN INC·Filed 2019·Application pending·0 cites
- 2149US2008213282A1FormulationsJACOB JABY·Filed 2007·Application pending·0 cites
- 2248US2022218607A1Stable, low-viscosity antibody formulations and uses thereofSANOFI SA·Filed 2020·Application pending·0 cites
- 2347US2024044912A1Means for antibody characterizationUNIV MICHIGAN REGENTS·Filed 2022·Application pending·0 cites
- 2447US2011226650A1Antibody formulationGENENTECH INC·Filed 2010·Application pending·0 cites
- 2547US2016251422A1Antibody formulationGENENTECH INC·Filed 2015·Application pending·0 cites
- 2642US2008003220A1Buffering agents for biopharmaceutical formulationsAMGEN INC·Filed 2007·Application pending·0 cites
- 2740US2004157796A1Concentrated liquid valdecoxib compositionFiled 2003·Application pending·0 cites
- 2840US2004127537A1Stable liquid parenteral parecoxib formulationFiled 2003·Application pending·0 cites
- 2939US2015315271A1FormulationsAMGEN INC·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →